These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 6101415)

  • 1. Allelic exclusion of glucose-6-phosphate dehydrogenase in platelets and T lymphocytes from a Wiskott-Aldrich syndrome carrier.
    Gealy WJ; Dwyer JM; Harley JB
    Lancet; 1980 Jan; 1(8159):63-5. PubMed ID: 6101415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wiskott-Aldrich syndrome: cellular impairments and their implication for carrier detection.
    Prchal JT; Carroll AJ; Prchal JF; Crist WM; Skalka HW; Gealy WJ; Harley J; Malluh A
    Blood; 1980 Dec; 56(6):1048-54. PubMed ID: 7437512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular expression of Wiskott-Aldrich allele.
    Carroll AJ; Prchal JT; Crist WM; Prchal JF
    Lancet; 1980 Mar; 1(8168 Pt 1):601-2. PubMed ID: 6102326
    [No Abstract]   [Full Text] [Related]  

  • 4. Wiskott-Aldrich syndrome in a female.
    Lutskiy MI; Sasahara Y; Kenney DM; Rosen FS; Remold-O'Donnell E
    Blood; 2002 Oct; 100(8):2763-8. PubMed ID: 12351383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The enigma of the Wiskott-Aldrich syndrome begins to unravel.
    Rosen FS
    J Clin Invest; 1996 Jun; 97(11):2407. PubMed ID: 8647931
    [No Abstract]   [Full Text] [Related]  

  • 6. Determination of carrier status for the Wiskott-Aldrich syndrome by flow cytometric analysis of Wiskott-Aldrich syndrome protein expression in peripheral blood mononuclear cells.
    Yamada M; Ariga T; Kawamura N; Yamaguchi K; Ohtsu M; Nelson DL; Kondoh T; Kobayashi I; Okano M; Kobayashi K; Sakiyama Y
    J Immunol; 2000 Jul; 165(2):1119-22. PubMed ID: 10878391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carrier detection in the Wiskott Aldrich syndrome.
    Fearon ER; Kohn DB; Winkelstein JA; Vogelstein B; Blaese RM
    Blood; 1988 Nov; 72(5):1735-9. PubMed ID: 3263154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atypical Wiskott-Aldrich syndrome in a girl.
    Conley ME; Wang WC; Parolini O; Shapiro DN; Campana D; Siminovitch KA
    Blood; 1992 Sep; 80(5):1264-9. PubMed ID: 1515642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. X-chromosome inactivation in the Wiskott-Aldrich syndrome: a marker for detection of the carrier state and identification of cell lineages expressing the gene defect.
    Greer WL; Kwong PC; Peacocke M; Ip P; Rubin LA; Siminovitch KA
    Genomics; 1989 Jan; 4(1):60-7. PubMed ID: 2563352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. WASP levels in platelets and lymphocytes of wiskott-aldrich syndrome patients correlate with cell dysfunction.
    Shcherbina A; Rosen FS; Remold-O'Donnell E
    J Immunol; 1999 Dec; 163(11):6314-20. PubMed ID: 10570326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Identification of two novel WASP gene mutations in 3 boys with Wiskott-Aldrich syndrome].
    Jiang LP; Xu YH; Yang XQ; Liu EM; Wang LJ; Lau YL; Chan KW
    Zhonghua Er Ke Za Zhi; 2003 Aug; 41(8):590-3. PubMed ID: 14744380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of X-chromosome inactivation and presumptive expression of the Wiskott-Aldrich syndrome (WAS) gene in hematopoietic cell lineages of a thrombocytopenic carrier female of WAS.
    Notarangelo LD; Parolini O; Porta F; Locatelli F; Lanfranchi A; Marconi M; Nespoli L; Albertini A; Craig IW; Ugazio AG
    Hum Genet; 1991 Dec; 88(2):237-41. PubMed ID: 1684569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant O-linked oligosaccharide biosynthesis in lymphocytes and platelets from patients with the Wiskott-Aldrich syndrome.
    Higgins EA; Siminovitch KA; Zhuang DL; Brockhausen I; Dennis JW
    J Biol Chem; 1991 Apr; 266(10):6280-90. PubMed ID: 2007580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carrier detection in Wiskott-Aldrich syndrome: combined use of M27 beta for X-inactivation studies and as a linked probe.
    Goodship J; Carter J; Espanol T; Boyd Y; Malcolm S; Levinsky RJ
    Blood; 1991 Jun; 77(12):2677-81. PubMed ID: 2043768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wiskott-Aldrich syndrome: detection of carrier state by metabolic stress of platelets.
    Shapiro RS; Gerrard JM; Perry GS; White JG; Krivit W; Kersey JH
    Lancet; 1978 Jan; 1(8056):121-3. PubMed ID: 87553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nature of the platelet defect in the Wiskott-Aldrich syndrome.
    Baldini MG
    Ann N Y Acad Sci; 1972 Oct; 201():437-44. PubMed ID: 4265132
    [No Abstract]   [Full Text] [Related]  

  • 17. Defective B-cell and regulatory T-cell function in Wiskott-Aldrich syndrome.
    Lau YL; Jones BM; Low LC; Wong SN; Leung NK
    Eur J Pediatr; 1992 Sep; 151(9):680-3. PubMed ID: 1396930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigen receptor-induced activation and cytoskeletal rearrangement are impaired in Wiskott-Aldrich syndrome protein-deficient lymphocytes.
    Zhang J; Shehabeldin A; da Cruz LA; Butler J; Somani AK; McGavin M; Kozieradzki I; dos Santos AO; Nagy A; Grinstein S; Penninger JM; Siminovitch KA
    J Exp Med; 1999 Nov; 190(9):1329-42. PubMed ID: 10544204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Wiskott-Aldrich syndrome protein (WASP): roles in signaling and cytoskeletal organization.
    Snapper SB; Rosen FS
    Annu Rev Immunol; 1999; 17():905-29. PubMed ID: 10358777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wiskott-Aldrich syndrome: another piece in the puzzle.
    Notarangelo LD; Mori L
    Clin Exp Immunol; 2005 Feb; 139(2):173-5. PubMed ID: 15654814
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.